Your AI-Trained Oncology Knowledge Connection!
Member, Community Oncology Editorial Board
Professor of Hematology/Oncology, Department of Internal Medicine
University of Nebraska Medical Center
Faculty of the Department of Medical Oncology
Morrison Cancer Center
Omaha, NE
Mehmet S. Copur, MD, FACP, is a nationally known medical oncologist in Grand Island, Nebraska and is affiliated with multiple hospitals in the area, including Veterans Affairs Black Hills Health Care System-Forte Mead and CHI Health St. Francis. He received his medical degree from Hacettepe University Faculty of Medicine in Turkey and has been in practice for more than 35 years. Copur is board-certified in Internal Medicine and Medical Oncology and serves on numerous committees.
The coronavirus disease 2019 (COVID-19) pandemic has permanently changed many aspects of clinical care, including clinical trials. A short list of the challenges faced by the entire research community during this pandemic include (but aren’t limited to) enrollment and protocol adherence difficulties, needing to reduce patient visits, staffing constraints, and limited availability of ancillary services.
A recap of some of the most notable ASCO 2020 research results in the field of gastrointestinal cancer that may guide oncologists in their day-to-day work.
A 51-year-old man noticed abdominal swelling and distention with intermittent abdominal pain, early satiety, and decreased appetite over the past several months. A computed tomography scan of the abdomen is performed. What's your diagnosis?
The 2019 American Society of Clinical Oncology (ASCO) Annual Meeting, which took place May 31–June 4 in Chicago, drew more than 32,000 oncology specialists from around the world.
The US Food and Drug Administration recently approved a new indication for olaparib for maintenance treatment in adult patients with germline or somatic BRCA-mutated advanced epithelial ovarian cancer.
This article reviews the current state of cancer research around the world.
This article reviews patient requests and how they may be in contrast with guidelines, and provides recommendations from a community oncology practice perspective.
In this article, we discuss why participation in clinical trials in the community oncology setting is often inadequate, how this affects cancer research, and the ways to close this gap.
In this case, we examine a 49-year-old man with widespread metastatic sclerotic bone lesions. What is your diagnosis?
